Article Text

Download PDFPDF

  1. Ashvini Keshavan1,
  2. David Breen1,
  3. Cecilia Theodore2,
  4. Anjum Misbahuddin1,
  5. Rajith De Silva1
  1. 1Essex Centre for Neurological Sciences
  2. 2Department of Genitourinary Medicine; Barking, Havering and Redbridge University Hospitals NHS Trust


Three women with neurological syndromes associated with Herpes Simplex type 2 (HSV2), diagnosed by PCR, are presented. Patient 1 had lymphocytic meningitis with no antecedent or concurrent genital symptoms. Patient 2 had chronic lymphocytic meningitis in the context of immunosuppressive medication and Mollaret cells in the cerebrospinal fluid. She has persistent neurological symptoms despite prolonged treatment with intravenous acyclovir, cessation of immunosuppression and clearance of viral nucleic acid from the cerebrospinal fluid. Patient 3 had a 6 year history of a recurrent vesicular eruption in a dermatomal distribution, accompanied by headache, neck stiffness, reduced speech output and confusion. Only Patient 3 gave a history of genital ulceration which had occurred during her initial clinical presentation, with no subsequent genital recurrences. While the role of long-term antiviral therapy is well-established in the prevention of genital recurrences, evidence for its efficacy in recurrent HSV2 meningitis is equivocal. Challenges encountered in managing these patients illustrate: (i) the protean neurological manifestations of HSV2 infection; (ii) the need for better evidence supporting acute and prophylactic antiviral treatment to prevent neurological recurrence; and (iii) the need to develop novel therapeutic approaches to prevent long term morbidity.


Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.